WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013119202) CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/119202 International Application No.: PCT/US2012/024009
Publication Date: 15.08.2013 International Filing Date: 06.02.2012
IPC:
A61K 39/00 (2006.01) ,C12Q 1/68 (2006.01)
Applicants: PROVIDENCE HEALTH & SERVICES - OREGON D/B/A PROVIDENCE PORTLAND MEDICAL CENTER[US/US]; 4805 NE Glisan Street Portland, OR 97213, US
Inventors: CURTI, Brendan; US
KOVACSOVICS-BANKOWSKI, Magdalena; US
WALKER, Ed; US
WALKER, Josh; US
WEINBERG, Andy; US
Agent: HAANES, Elizabeth, J.; Sterne Kessler Goldstein & Fox, P.L.L.C. 1100 New York Avenue, NW Washington, DC 20005, US
Priority Data:
Title (EN) CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS
(FR) TRAITEMENT DU CANCER ET PROCÉDÉS DE SURVEILLANCE UTILISANT DES AGONISTES DE OX40
Abstract:
(EN) OX40 is a potent immune stimulating target. Provided herein are methods for the treatment of cancer patients using (3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40-induced T cell proliferation.
(FR) OX40 est une cible d'immunostimulation puissante. La présente invention concerne des procédés pour le traitement de patients cancéreux en utilisant des agonistes de OX40, des procédés pour prédire le résultat clinique du traitement par corrélation du traitement et d'une augmentation de la prolifération de lymphocytes T induite par OX40.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)